The framework has shifted from markup to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 1.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 16%. Our forward projection puts the odds of a 10% gain over the next month near 12%. The street (21 analysts) rates it strong buy, with a mean price target of $534.
S&P Global
SPGI · a US exchange · USD · Market cap $126.6B · 44,500 employees
S&P Global Inc., together with its subsidiaries, provides benchmarks, data, analytics, and workflow solutions in the global capital, energy and commodity, and automotive markets.
FAIL · Does not pass the screenAt the last full screen
2026-09-08
Screened 2026-09-08 · the tape above runs as of 09:00 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
This name holds its markup label.
S&P Global holds its Markup at $429.31. The statistical read favours the buyers, held for 51 days.
| Phase | Markup |
| Quantitative state | The statistical read favours the buyers, held for 51 days |
| Price at the screen | $429.31 |
| Valuation | 26.16 trailing · 21.23 forward price to earnings |
| Values screen | FAIL · score 10.0 |
| Beta | 1.08 |
Five Screens, Shown in Full
Does not pass. Business activity screen
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Excluded | Core business clean | Business activity: Financials sector | Fail |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is WorthThe Fair Value Range
Our framework reads AVOID: it trades above our $414.14 fair value estimate, moderate competitive moat, 10.40% revenue growth.
Fair value range in USD, drawn from the 2026-09-08 screen. The gold marker is the market price at the same screen. The price runs 3.5% above the base estimate.
Third-party analyst targets: 20 covering, consensus Strong Buy. The average target sits +22% from the screen price.
Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-08 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsS&P Global's Ethical Lapses Outweigh Value
Imagine any financial decision-maker, from a Wall Street analyst to a Main Street investor, and they're likely relying on S&P Global's benchmarks and analytics. The firm is a titan in the financial data and stock exchanges market, offering essential insights in capital, energy, commodity, and automotive sectors. Yet, despite a robust 10% revenue growth and a healthy 31% profit margin, there's a fly in the ointment - its ethical failings.
Why it stands out, or rather, why we pass - S&P Global has a moderate competitive moat and a forward P/E of 21.4x, which might suggest a reasonably valued stock in a growth market. However, its failure on our ethical screen is a critical red flag. When a firm can't meet basic ethical standards, it raises questions about its long-term sustainability and societal value.
The risk here is twofold: the first is the ethical risk, as failing our business activity screen means S&P Global is involved in activities we deem incompatible with our ethical-first approach. The second is the market risk, as the stock is currently trading above our fair value of $413.30, indicating a potential overvaluation. While the consensus rating from analysts is a strong buy with a lofty median target of $523, we cannot overlook the ethical concerns. Analysis, not advice.
| Forward P/E | 21.2xexpensive even after accounting for its growth |
| Trailing P/E | 26.2xa premium valuation |
| EPS, trailing | 16.41 |
| EPS, forward | 20.22 |
| Revenue growth | +10.4%steady growth |
| Profit margin | 30.5%highly profitable on every dollar of sales |
| Return on equity | 14.3%a solid return on shareholder capital |
| FCF yield | 4.30% |
| Dividend yield | 92.00% |
| Debt to equity | 0.43minimal debt: a conservative balance sheet |
| Current ratio | 0.95below 1: short-term bills exceed liquid assets |
| Beta | 1.08moves a little more than the market |
| Short interest, float | 0.03% |
| 52-week range | 361.03 - 522.47 |
| Moat | MODERATE |
| Market cap | $126.6B |
| Employees | 44,500 |
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeSPGI trades on a US exchange. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 16%. Our forward projection puts the odds of a 10% gain over the next month near 12%. The street (21 analysts) rates it strong buy, with a mean price target of $534. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 16%. Our forward projection puts the odds of a 10% gain over the next month near 12%. The street (21 analysts) rates it strong buy, with a mean price target of $534. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 16%. Our forward projection puts the odds of a 10% gain over the next month near 12%. The street (21 analysts) rates it strong buy, with a mean price target of $534. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 16%. Our forward projection puts the odds of a 10% gain over the next month near 12%. The street (21 analysts) rates it strong buy, with a mean price target of $534. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 5.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 16%. Our forward projection puts the odds of a 10% gain over the next month near 12%. The street (21 analysts) rates it strong buy, with a mean price target of $534. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 16%. Our forward projection puts the odds of a 10% gain over the next month near 12%. The street (21 analysts) rates it strong buy, with a mean price target of $534. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 6.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 16%. Our forward projection puts the odds of a 10% gain over the next month near 12%. The street (21 analysts) rates it strong buy, with a mean price target of $534. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 16%. Our forward projection puts the odds of a 10% gain over the next month near 12%. The street (21 analysts) rates it strong buy, with a mean price target of $534.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Is Applied Materials Stock Amplifying A Risk You Already Own? Trefis · 8d ago
- Qualcomm Stock Looks Cheap, But Is The Discount Deserved? Trefis · 8d ago
- Should You Buy Meta Stock For Cash Flow It Plans To Spend? Trefis · 8d ago
- How Far Could Boeing Stock Fall If The Market Turns? Trefis · 8d ago
- Is Accenture's Business Falling As Fast As Its Stock? Trefis · 8d ago
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-01 | CLAY CATHERINE R | Officer | 2,500 | $1,078,475 | |
| 2026-04-30 | MORITZ ROBERT EDWARD JR. | Director | 1,151 | $500,001 | |
| 2026-04-29 | CHEUNG MARTINA | Chief Executive Officer | 2,322 | $998,297 | |
| 2026-04-01 | CRAIG CHRISTOPHER | Officer | 1,480 | $629,252 | |
| 2026-02-27 | ABOAF ERIC W | Chief Financial Officer | 1,091 | $482,091 | |
| 2026-02-24 | SAHA SAUGATA | Officer | 7,551 | · | |
| 2026-02-24 | MOORE SALLY ANN | Officer | 3,775 | · | |
| 2026-02-24 | GANESAN GIRISH | Officer | 1,226 | · | |
| 2026-02-24 | TWOMEY CHRISTINA | Officer | 546 | · | |
| 2026-02-24 | LE PALLEC YANN | Officer | 1,698 | · |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 27 Mar2026 | Alan Armstrong | Republican | buy | 1K–15K |
| 2026-04-13 | Ro Khanna | Democrat | Sale | 1K–15K |
| 17 Jun2026 | Jared Moskowitz | Democrat | sell | 1K–15K |
| 17 Jun2026 | Jared Moskowitz | Democrat | sell | 1K–15K |
| 17 Jun2026 | Jared Moskowitz | Democrat | sell | 1K–15K |
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $420.02 | +1.5% | $0.97 | $1,018 | +1.8% |
| 2 months | $414.46 | +2.9% | $0.97 | $1,031 | +3.1% |
| 3 months | $418.73 | +1.8% | $0.97 | $1,021 | +2.1% |
| 6 months | $495.25 | -13.9% | $1.94 | $865 | -13.5% |
| 1 year | $509.65 | -16.3% | $3.86 | $844 | -15.6% |
| 2 years | $423.35 | +0.7% | $7.60 | $1,025 | +2.5% |
| 3 years | $374.79 | +13.8% | $11.22 | $1,168 | +16.8% |
| 5 years | $376.40 | +13.3% | $17.88 | $1,180 | +18.0% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever SPGI does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.